Overexpression of minichromosome maintenance protein 10 in medulloblastoma and its clinical implications
暂无分享,去创建一个
M. Kool | E. Özer | S. Madlener | E. Erkan | O. Saydam | T. Ströbel | N. Saydam | G. Jungwirth | D. Senfter
[1] Peir-In Liang,et al. MCM10 overexpression implicates adverse prognosis in urothelial carcinoma , 2016, Oncotarget.
[2] Giles W. Robinson,et al. Medulloblastoma—translating discoveries from the bench to the bedside , 2014, Nature Reviews Clinical Oncology.
[3] B. Stillman,et al. Structural and mechanistic insights into Mcm2–7 double-hexamer assembly and function , 2014, Genes & development.
[4] B. Tannous,et al. Depletion of minichromosome maintenance protein 7 inhibits glioblastoma multiforme tumor growth in vivo , 2014, Oncogene.
[5] I. Symeonidou,et al. Licensing of DNA replication, cancer, pluripotency and differentiation: an interlinked world? , 2014, Seminars in cell & developmental biology.
[6] A. Riera,et al. Helicase loading: how to build a MCM2-7 double-hexamer. , 2014, Seminars in cell & developmental biology.
[7] A. Bielinsky,et al. MCM10: one tool for all-Integrity, maintenance and damage control. , 2014, Seminars in cell & developmental biology.
[8] Roland Eils,et al. Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. , 2014, Cancer cell.
[9] C. Hawkins,et al. Overcoming resistance to sonic hedgehog inhibition by targeting p90 ribosomal S6 kinase in pediatric medulloblastoma , 2014, Pediatric blood & cancer.
[10] J. Walter,et al. Prereplication-complex formation: a molecular double take? , 2014, Nature Structural &Molecular Biology.
[11] S. S. Yadav,et al. Over Expression of Minichromosome Maintenance Genes is Clinically Correlated to Cervical Carcinogenesis , 2013, PloS one.
[12] P. Carmeliet,et al. Targeting Placental Growth Factor/Neuropilin 1 Pathway Inhibits Growth and Spread of Medulloblastoma , 2013, Cell.
[13] Scott L. Pomeroy,et al. Medulloblastomics: the end of the beginning , 2012, Nature Reviews Cancer.
[14] Matthew J. Betts,et al. Dissecting the genomic complexity underlying medulloblastoma , 2012, Nature.
[15] Elaine R. Mardis,et al. Novel mutations target distinct subgroups of medulloblastoma , 2012, Nature.
[16] Jill P. Mesirov,et al. MEDULLOBLASTOMA EXOME SEQUENCING UNCOVERS SUBTYPE-SPECIFIC SOMATIC MUTATIONS , 2012, Nature.
[17] D. Di Paola,et al. Comparative analysis of pre‐replication complex proteins in transformed and normal cells , 2012, Journal of cellular biochemistry.
[18] Scott L. Pomeroy,et al. Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas , 2012, Acta Neuropathologica.
[19] Scott L. Pomeroy,et al. Molecular subgroups of medulloblastoma: the current consensus , 2011, Acta Neuropathologica.
[20] Hendrik Witt,et al. Medulloblastoma comprises four distinct molecular variants. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] Y. Wang,et al. Minichromosome maintenance proteins 2, 3 and 7 in medulloblastoma: overexpression and involvement in regulation of cell migration and invasion , 2010, Oncogene.
[22] M. Méchali,et al. Eukaryotic DNA replication origins: many choices for appropriate answers , 2010, Nature Reviews Molecular Cell Biology.
[23] G. Riggins,et al. Evaluation of retinoic acid therapy for OTX2-positive medulloblastomas. , 2010, Neuro-oncology.
[24] T. Wurdinger,et al. Comparative protein profiling reveals minichromosome maintenance (MCM) proteins as novel potential tumor markers for meningiomas. , 2010, Journal of proteome research.
[25] Z. Kelman,et al. Alternative Mechanisms for Coordinating Polymerase α and MCM Helicase , 2009, Molecular and Cellular Biology.
[26] E. Lalli,et al. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells , 2008, Oncogene.
[27] Dirk Troost,et al. Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features , 2008, PloS one.
[28] T. Merchant,et al. Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] Jong Hoon Park,et al. Knockdown of human MCM10 activates G2 checkpoint pathway. , 2008, Biochemical and biophysical research communications.
[30] R. Versteeg,et al. Direct regulation of the minichromosome maintenance complex by MYCN in neuroblastoma. , 2007, European journal of cancer.
[31] A. Bielinsky,et al. Human Mcm10 regulates the catalytic subunit of DNA polymerase-alpha and prevents DNA damage during replication. , 2007, Molecular biology of the cell.
[32] T. Merchant,et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. , 2006, The Lancet. Oncology.
[33] K. Ness,et al. Physical performance limitations and participation restrictions among cancer survivors: a population-based study. , 2006, Annals of epidemiology.
[34] Amar Gajjar,et al. Late neurocognitive sequelae in survivors of brain tumours in childhood. , 2004, The Lancet. Oncology.
[35] Anindya Dutta,et al. DNA replication in eukaryotic cells. , 2002, Annual review of biochemistry.